Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan + sitafloxacin + amoxicillin for refractory Helicobacter pylori infection
TCTR20211203002Phase 3Not yet recruiting
- Sponsor
- Routine to Research Unit, Siriraj Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vonoprazan, sitafloxacin, amoxicillin in Helicobacter pylori infection, sponsored by Routine to Research Unit, Siriraj Hospital. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
vonoprazansitafloxacinamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on TCTR20211203002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211203002.